Open study for the evaluation of the effectiveness of insulin buccal spray on metabolic control in patients with impaired glucose tolerance (PREVORAL study 2) [Studio aperto per la valutazione dell efficacia dell insulina spray buccale sul controllo glicometabolico in soggetti con ridotta tolleranza ai carboidrati (studio PREVORAL 2)]
Phase of Trial: Phase II
Latest Information Update: 05 Oct 2012
At a glance
- Drugs Insulin (Primary)
- Indications Glucose intolerance; Hyperglycaemia; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms PREVORAL2
- 05 Oct 2012 Results presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.
- 05 Oct 2012 Status changed from active, no longer recruiting to completed, based on the abstract presented at EASD.
- 08 Dec 2011 Results presented at the 21st World Diabetes Congress.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History